h1. Bootstrap heading | Semibold 36px |
h2. Bootstrap heading | Semibold 30px |
h3. Bootstrap heading | Semibold 24px |
h4. Bootstrap heading | Semibold 18px |
h5. Bootstrap heading | Semibold 14px |
【福利】严选治愈 | Semibold 12px |
当前市值之下，以岭的创新溢价几乎未被计价，随着业绩显露，价值重估或许只是时间问题。以岭药业凭借其
然而，当前市场给以岭的估值，仍很大程度上沿用传统中药PE框架，却鲜少对其研发管线给予溢价。被忽略
若以分部估值视角看：-成熟业务年利润约16亿对应15倍PE，即240亿市值然而，当前市场给以岭的
-仅化药管线中两款临近上市品种（如苯胺洛芬注射液、XY0206片），假设每款贡献10亿收入，按3
然而，当前市场给以岭
这种上市一批、申报一批、在研一批的节奏，在国内中药企业中并不多见往回看，过去5年，以
| # | First Name | Last Name | Username |
|---|---|---|---|
| 1 | Mark | Otto | @mdo |
| 2 | Jacob | Thornton | @fat |
| 3 | Larry | the Bird |
| Class | Description |
|---|---|
.active | Applies the hover color to a particular row or cell |
.success | Indicates a successful or positive action |
.info | Indicates a neutral informative change or action |
.warning | Indicates a warning that might need attention |
.danger | Indicates a dangerous or potentially negative action |
| # | Column heading | Column heading | Column heading |
|---|---|---|---|
| 1 | Column content | Column content | Column content |
| 2 | Column content | Column content | Column content |
| 3 | Column content | Column content | Column content |
| 4 | Column content | Column content | Column content |
| 5 | Column content | Column content | Column content |
| 6 | Column content | Column content | Column content |
| 7 | Column content | Column content | Column content |
| 8 | Column content | Column content | Column content |
| 9 | Column content | Column content | Column content |
